Haisco licenses pre-clinical drug to US venture for $1.5 billion

Haisco licenses pre-clinical drug to US venture for $1.5 billion
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.